- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03914989
Sensory Enrichment for Older Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to explore sensory stimulation as a potential means of enhancing cognitive abilities. In mice, multi-odorant enrichment has been shown to increase neurogenesis in a critical memory pathway and thereby improve memory. In this clinical study, we will determine if a nightly sensory enrichment regimen using scents for 6 months can improve cognitive skills, as measured using a series of cognitive assessments and brain imaging in older adults. We also will determine if mood/mental state of mind or olfactory functioning improve following scent stimulation.
This study will enroll approximately 200 participants. Of the 200 participants in the study, 50 individuals, who are interested in participating, will have a functional Magnetic Resonance Imaging (fMRI) scan at the beginning and end of the study, which will be used to examine changes in the brain.
Participants will undergo cognitive assessments, computerized cognitive assessments, and olfactory function assessments. They will be randomly assigned to either an experimental or an active control group, and will be exposed to either a higher or lower concentration of essential oils nightly using a nebulizing fragrance diffuser, rotating through seven different scents, one per night. The exposures will continue for 6 months, after which the participants will return and undergo the same assessments conducted at the beginning of the study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Blake A Miranda, BS
- Phone Number: 949-824-0904
- Email: bamirand@uci.edu
Study Contact Backup
- Name: Michael Leon, PhD
- Phone Number: 949-237-3026
- Email: mleon@uci.edu
Study Locations
-
-
California
-
Irvine, California, United States, 92697
- University of California Irvine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Are age 60-85, male or female
- Have normal cognition (determined at first assessment with cognitive testing)
- Speak/read/understand English fluently
- Have visual and auditory acuity adequate for neuropsychological and computerized testing
- Are in good general health with no disease(s) expected to interfere with the study
- Are willing and able to participate for the duration of the study and in all study procedures
- Are able to smell scents
- Are willing to refrain from using scented candles, scented oils, or air fresheners while participating in the study
Are willing to travel to the research site for testing
If interested in functional Magnetic Resonance Imaging (fMRI),
- Are willing and able to participate in the fMRI scan.
Exclusion Criteria:
- Have known fragrance sensitivities
- Have asthma, allergies, or a fragrance sensitivity, which produces symptoms similar to those of an allergy, including runny nose, watery eyes, sneezing, or skin rash
- Have a neurologic disease such as Parkinson's disease, multiple sclerosis, brain cyst, tumor or aneurysm
- Have major health conditions such as uncontrolled diabetes mellitus, uncontrolled hypertension, nutritional deficiency or thyroid disease
- Have significant psychiatric disorders such as schizophrenia, bipolar disorder, anxiety disorder, or attention-deficit hyperactivity disorder
- Have cognitive impairment when tested at baseline (defined as a score on any neuropsychological test of 1.5 standard deviations or more outside the age norm)
- Have had alcohol or substance abuse or dependence within the past 2 years (DSM-IV criteria)
Smoke cigarettes, e-cigarettes, cigars, marijuana, or any other substance that could produce an interfering odor for the study.
If interested in functional Magnetic Resonance Imaging (fMRI),
- MRI contraindications, (e.g. pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental group
Individuals in this group receive exposure to a higher concentration of essential oil fragrances nightly.
|
Participants will be exposed to either a higher or lower concentration of essential oils nightly for two hours as they are going to sleep, using a nebulizing fragrance diffuser, rotating through seven different scents, one per night.
|
Placebo Comparator: Active control group
Individuals in this group receive exposure to a lower concentration of essential oil fragrances nightly.
|
Participants will be exposed to either a higher or lower concentration of essential oils nightly for two hours as they are going to sleep, using a nebulizing fragrance diffuser, rotating through seven different scents, one per night.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of behavioral pattern separation ability
Time Frame: 1) at Baseline and 2) after 6 months of intervention
|
Change in lure discrimination index on a computerized mnemonic discrimination task.
|
1) at Baseline and 2) after 6 months of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of cognition
Time Frame: 1) at Baseline and 2) after 6 months of intervention
|
Change in cognitive ability will be measured using scores from a neuropsychological battery.
For each subsection, a change score will be calculated using the difference between baseline and 6-month scores, and the change score will be compared between groups.
Higher values indicate a better outcome.
|
1) at Baseline and 2) after 6 months of intervention
|
Evaluation of depression
Time Frame: 1) at Baseline and 2) after 6 months of intervention
|
Change in depression status using the Beck Depression Inventory.
|
1) at Baseline and 2) after 6 months of intervention
|
Evaluation of quality of life
Time Frame: 1) at Baseline and 2) after 6 months of intervention
|
Change in quality of life using the Farage Quality of Life questionnaire.
|
1) at Baseline and 2) after 6 months of intervention
|
Evaluation of olfactory function
Time Frame: 1) at Baseline and 2) after 6 months of intervention
|
Change from baseline score on the Sniffin' Sticks instrument to assess olfactory system functioning.
|
1) at Baseline and 2) after 6 months of intervention
|
Evaluation of change in brain structural connectivity
Time Frame: 1) at Baseline and 2) after 6 months of intervention
|
Change in perforant path integrity using functional Magnetic Resonance Imaging.
|
1) at Baseline and 2) after 6 months of intervention
|
Evaluation of change in brain structures
Time Frame: 1) at Baseline and 2) after 6 months of intervention
|
Change in thickness of entorhinal cortex using functional Magnetic Resonance Imaging.
|
1) at Baseline and 2) after 6 months of intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2014-1078
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Function
-
University School of Physical Education in WroclawActive, not recruitingCognitive Function | Executive FunctionPoland
-
Maastricht UniversityWageningen University and Research; Top Institute Food and Nutrition; Netherlands...TerminatedCognitive Function | Ageing | Physical Function | Mitochondrial FunctionNetherlands
-
University Hospital, GenevaCompletedCognitive Function | Falls | Physical FunctionSwitzerland
-
University of FloridaNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedCognitive Function | Older Adults | Physical FunctionUnited States
-
Columbia UniversityNational Institute on Aging (NIA)Terminated
-
Örebro University, SwedenNot yet recruiting
-
Radicle ScienceActive, not recruitingCognitive FunctionUnited States
-
Vanderbilt University Medical CenterCompletedCognitive Function
-
Maastricht University Medical CenterBioActor B.V.Completed
-
University of OstravaCompletedCognitive FunctionCzechia
Clinical Trials on olfactory enrichment (essential oils)
-
Ditte Gertz MogensenRecruiting
-
University Hospital, LilleRecruiting
-
Etablissement Public de Santé Barthélemy DurandRecruitingPsychiatric Disorder | Benzodiazepine WithdrawalFrance
-
Center Eugene MarquisTerminated
-
Özlem ÇağanCompletedAnxiety | Aromatherapy | Pain, LaborTurkey
-
University of AlbertaTaiga BioActives Inc.WithdrawnUrinary Tract InfectionsCanada
-
Centre Francois BaclesseCompletedNausea and Vomiting | Aromatherapy | Essential Oil | Suportive CareFrance
-
Show Chwan Memorial HospitalRecruitingPain | Anxiety | Heart Rate VariabilityTaiwan
-
Clinica Luganese MoncuccoCompletedBPSD (Behavioral and Psycological Symptoms of Dementia)Switzerland